BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35816469)

  • 1. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
    Secinti IE; Ozgur T; Gursoy D; Dede I
    APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
    Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
    Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
    Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
    Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
    Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
    Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
    Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
    Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumour budding in stomach cancers.
    Kucuk S
    Int J Clin Pract; 2021 Dec; 75(12):e14922. PubMed ID: 34580963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
    Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
    Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
    Lohneis P; Hieggelke L; Gebauer F; Ball M; Bruns C; Büttner R; Löser H; Quaas A
    Virchows Arch; 2021 Mar; 478(3):393-400. PubMed ID: 32761393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing tumor budding in cholangiocarcinoma is associated with decreased disease-specific survival.
    Agostini-Vulaj D; Cates JMM; Bratton LE; Gonzalez RS
    Hum Pathol; 2021 May; 111():75-83. PubMed ID: 33727168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
    Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
    Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
    Neppl C; Zlobec I; Schmid RA; Berezowska S
    Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
    Roy P; Datta J; Roy M; Mallick I; Mohandas M
    Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma.
    Jesinghaus M; Herz AL; Kohlruss M; Silva M; Grass A; Lange S; Novotny A; Ott K; Schmidt T; Gaida M; Hapfelmeier A; Denkert C; Weichert W; Keller G
    J Pathol Clin Res; 2022 Sep; 8(5):448-457. PubMed ID: 35715937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful Results.
    Cho SJ; Kakar S
    Arch Pathol Lab Med; 2018 Aug; 142(8):952-957. PubMed ID: 30040461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
    Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
    Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.